Atrium Innovations Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Atrium Innovations Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3310
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Atrium Innovations Inc (Atrium) is a provider of science-based natural health products. The company develops, manufactures and markets nutritional and dietary supplements. Its major products include minerals, vitamins and specialized products such as enzymes and probiotics. Atrium markets its products under brands such as Garden of Life, Klean Athlete, Minami and Orthica, among others. It has partnerships with academic institutes such as Institute of Nutrition and Functional Foods at Laval University; Cleveland Clinic Center for Functional Medicine and other commercial partners. The company also supports research projects at academic centers across the world. The company has manufacturing facilities in the US, Canada, Europe and Argentina. Atrium is headquartered in Quebec, Canada.

Atrium Innovations Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atrium Innovations Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Permira Funds Completes Acquisition Of Atrium Innovations For US$1.04 Billion 10
Partnerships 13
Atrium Innovations Forms Joint Venture With Fosun Industrial 13
Licensing Agreements 14
Atrium Innovations Enters Into Licensing Agreement With Juvenon 14
Acquisition 15
Nestle to Acquire Atrium Innovations for USD2.3 Billion 15
Atrium Innovations Acquires 70% Stake In Mucos Pharma 17
Atrium Innovations Inc – Key Competitors 18
Atrium Innovations Inc – Key Employees 19
Atrium Innovations Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Key Facts 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atrium Innovations Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atrium Innovations Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Permira Funds Completes Acquisition Of Atrium Innovations For US$1.04 Billion 10
Atrium Innovations Forms Joint Venture With Fosun Industrial 13
Atrium Innovations Enters Into Licensing Agreement With Juvenon 14
Nestle to Acquire Atrium Innovations for USD2.3 Billion 15
Atrium Innovations Acquires 70% Stake In Mucos Pharma 17
Atrium Innovations Inc, Key Competitors 18
Atrium Innovations Inc, Key Employees 19
Atrium Innovations Inc, Subsidiaries 20
Atrium Innovations Inc, Joint Venture 21

List of Figures
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Atrium Innovations Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Skandinaviska Enskilda Banken AB:企業のM&A・事業提携・投資動向
    Skandinaviska Enskilda Banken AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Skandinaviska Enskilda Banken AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Baoviet Holdings:企業の戦略・SWOT・財務分析
    Baoviet Holdings - Strategy, SWOT and Corporate Finance Report Summary Baoviet Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Singapore Airlines Ltd:企業のM&A・事業提携・投資動向
    Singapore Airlines Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Singapore Airlines Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Australian Vanadium Ltd (YRR):企業の財務・戦略的SWOT分析
    Summary Australian Vanadium Ltd (AVL), formerly Yellow Rock Resources Ltd, is a mining company that explores and develops titanium, vanadium, copper, gold, and uranium metals. The company’s projects include Gabanintha Gold Copper Project, The Australian Vanadium Project, Coates Vanadium Project, Now …
  • JSC Gazprom Neft:企業の戦略・SWOT・財務情報
    JSC Gazprom Neft - Strategy, SWOT and Corporate Finance Report Summary JSC Gazprom Neft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Intuit Inc (INTU):企業の財務・戦略的SWOT分析
    Intuit Inc (INTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • American Express Company:企業の戦略・SWOT・財務情報
    American Express Company - Strategy, SWOT and Corporate Finance Report Summary American Express Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Inspire Medical Systems Inc (INSP):医療機器:M&Aディール及び事業提携情報
    Summary Inspire Medical Systems Inc (Inspire) is a medical device company that manufactures and markets healthcare implants. The company offers implanted neurostimulation device. It offers product is used for treatment of obstructive sleep apnea. Inspire uses neurostimulation technologies. The compa …
  • Yokogawa Electric Corp (6841):企業の財務・戦略的SWOT分析
    Yokogawa Electric Corp (6841) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Novartis AG:企業の戦略・SWOT・財務情報
    Novartis AG - Strategy, SWOT and Corporate Finance Report Summary Novartis AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Onxeo SA (ONXEO):企業の財務・戦略的SWOT分析
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as beleodaq and asidna among others. It offers drugs for the treatment of liver cancer, and treatment and pr …
  • Elite Pharmaceuticals Inc (ELTP):企業の財務・戦略的SWOT分析
    Elite Pharmaceuticals Inc (ELTP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Duro Dakovic Group Plc:企業の戦略・SWOT・財務情報
    Duro Dakovic Group Plc - Strategy, SWOT and Corporate Finance Report Summary Duro Dakovic Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Northern Trust Corporation:企業のM&A・事業提携・投資動向
    Northern Trust Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Northern Trust Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • William Hill plc (WMH):企業の財務・戦略的SWOT分析
    William Hill plc (WMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • 7-Eleven Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary 7-Eleven, Inc (7-Eleven) a subsidiary of Seven-Eleven Japan Co., Ltd., is a convenience store chain operator. The company operates through franchise and license models and offers a range of merchandises. It also operates as an independent gasoline retailer. The company’s store offers various …
  • Janus Henderson Group Plc:企業の戦略・SWOT・財務情報
    Janus Henderson Group Plc - Strategy, SWOT and Corporate Finance Report Summary Janus Henderson Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dai-ichi Life Holdings, Inc.:企業のM&A・事業提携・投資動向
    Dai-ichi Life Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dai-ichi Life Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • British Airways Plc:企業の戦略的SWOT分析
    British Airways Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Pilatus Group:企業の戦略・SWOT・財務情報
    Pilatus Group - Strategy, SWOT and Corporate Finance Report Summary Pilatus Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆